- Home
- CDXS vs EVM Comparison
CDXS vs EVM Comparison
Compare CDXS & EVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- EVM
- Stock Information
- Founded
- CDXS 2002
- EVM 2002
- Country
- CDXS United States
- EVM United States
- Employees
- CDXS N/A
- EVM N/A
- Industry
- CDXS Major Chemicals
- EVM Finance/Investors Services
- Sector
- CDXS Industrials
- EVM Finance
- Exchange
- CDXS Nasdaq
- EVM Nasdaq
- Market Cap
- CDXS 230.3M
- EVM 230.9M
- IPO Year
- CDXS 2010
- EVM N/A
- Fundamental
- Price
- CDXS $2.11
- EVM $8.78
- Analyst Decision
- CDXS Buy
- EVM
- Analyst Count
- CDXS 2
- EVM 0
- Target Price
- CDXS $11.00
- EVM N/A
- AVG Volume (30 Days)
- CDXS 1.1M
- EVM 55.8K
- Earning Date
- CDXS 05-01-2025
- EVM 01-01-0001
- Dividend Yield
- CDXS N/A
- EVM 4.01%
- EPS Growth
- CDXS N/A
- EVM N/A
- EPS
- CDXS N/A
- EVM 0.20
- Revenue
- CDXS $59,345,000.00
- EVM N/A
- Revenue This Year
- CDXS $12.62
- EVM N/A
- Revenue Next Year
- CDXS $22.11
- EVM N/A
- P/E Ratio
- CDXS N/A
- EVM $47.61
- Revenue Growth
- CDXS N/A
- EVM N/A
- 52 Week Low
- CDXS $1.90
- EVM $7.67
- 52 Week High
- CDXS $6.08
- EVM $9.59
- Technical
- Relative Strength Index (RSI)
- CDXS 35.96
- EVM 35.58
- Support Level
- CDXS $1.91
- EVM $8.49
- Resistance Level
- CDXS $2.47
- EVM $8.86
- Average True Range (ATR)
- CDXS 0.21
- EVM 0.18
- MACD
- CDXS 0.02
- EVM -0.04
- Stochastic Oscillator
- CDXS 23.86
- EVM 25.22
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income and alternative strategies to institutional investors, both in the United States and internationally.